Related Experiment Videos
A comparison of gene transfer methods in human dendritic cells
J F Arthur1, L H Butterfield, M D Roth
1Division of Surgical Oncology, University of California at Los Angeles School of Medicine 90095-1782, USA.
Cancer Gene Therapy
|January 1, 1997
Summary
Recombinant adenovirus vectors efficiently transduce human dendritic cells (DCs), a type of antigen-presenting cell. This gene transfer method shows promise for genetically engineering DCs for therapeutic applications.
Area of Science:
- Immunology
- Cell Biology
- Gene Therapy
Background:
- Dendritic cells (DCs) are potent antigen-presenting cells (APCs) crucial for initiating T-cell responses.
- Enriching DCs from peripheral blood leukocytes is feasible through short-term culture with IL-4 and GM-CSF.
- Effective gene transfer into human DCs is essential for their therapeutic manipulation.
Purpose of the Study:
- To evaluate various gene transfer methods for human dendritic cells (DCs).
- To assess the efficiency and utility of recombinant adenovirus (AdV) vectors for DC gene engineering.
Main Methods:
- Dendritic cells (DCs) were enriched from peripheral blood leukocytes.
- Gene transfer was attempted using DNA/liposome complexes, electroporation, CaPO4 precipitation, and recombinant adenovirus (AdV) vectors.
- Expression levels were analyzed across a range of AdV multiplicities of infection (MOI).
Main Results:
- Physical gene transfer methods yielded low expression levels in DCs.
- Recombinant AdV vectors efficiently transduced human DCs, achieving >95% efficiency at high MOI.
- AdV vectors facilitated the expression of reporter genes and cytokines (IL-2, IL-7) in DCs.
Conclusions:
- Recombinant adenovirus vectors represent a promising tool for the genetic engineering of human dendritic cells.
- Efficient gene transfer into DCs using AdV vectors opens avenues for enhanced immunotherapies.
- Further optimization may improve gene expression levels in DCs for clinical applications.